Towards Clinical Integration of a SPECT Detection Module for BNCT Dose Monitoring

Le résumé fourni par la source

Boron Neutron Capture Therapy (BNCT) is a targeted radiotherapy that requires precise dose monitoring to ensure effective treatment. We initially report experimental measurements performed with the BeNEdiCTE detector, designed for SPECT-based dose monitoring in BNCT. The detector is based on a co-doped LaBr 3 (Ce, Sr) monolithic crystal read out by Silicon Photomultipliers and compact electronics. Tomographic measurements were performed at the Laboratorio di Energia Nucleare Applicata in Pavia (Italy). Then, measurements with neutron conditions similar to those expected in clinical treatments were performed at the Nagoya University Acceleratordriven Neutron Source (Japan). The detector demonstrated the ability to detect the 478 keV gamma rays emitted during boron neutron capture reactions. Additionally, the detector successfully reconstructed 2D and 3D images of the boron distribution with sub-centimeter resolution. The measurements highlighted key areas for improvement to make the detector suitable for clinical use with patients, which will be presented in detail in this work. The boron present in the FR4 material used in the electronics boards was identified as a significant source of 478-keV gamma rays uncorrelated with the imaged object. To mitigate this, a new substrate material, RO3003, was tested, showing a substantial reduction in gamma rays emitted at 478 keV. Furthermore, the detector’s electronics were optimized to improve count-rate capability. This involved reducing the dead time from 5.4 µs to 2.1 µs and refining an energy thresholding mechanism to process only events around 478 keV. These improvements will enhance the detector’s performance, bringing it closer to clinical use with patients.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.